Invesaro

Stocks Health care HUM

NYSE · Health care

Humana Inc (HUM)

Humana Inc brought in $137.2B of revenue over the twelve months to March 31, 2026, up 14.1% from a year earlier. Net income was $1.1B, a net margin of 0.8%. Operating cash flow minus capital spending left $375M of free cash flow in fiscal 2025. At March 31, 2026 it held $5B in cash against $12.3B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 29, 2026.

Price
$404.07
+4.05% on the day · October 5, 2026
52-week range $163.11 to $428.88
Market cap
$48.5B
Revenue (last 12 months)
$137.2B
+14.1% year on year
Net margin
0.8%
P/E
41.1
on FY2025 diluted EPS

Key facts about Humana Inc

Net worth
Humana Inc has a market value (market cap) of $48.5B at the latest share price, and shareholders' equity of $18.6B on its balance sheet at March 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $129.7B (+10.1% year on year), with net income of $1.2B. Over the 12 months to March 31, 2026: revenue $137.2B, net income $1.1B.
Cash flow
In fiscal 2025 operations brought in $921M of cash; after $546M of capital spending, free cash flow was $375M.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on July 29, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Humana Inc's next report is expected around November 4, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Dividend
Humana Inc paid dividends of $3.54 per share in fiscal 2025, a yield of 0.88% at the current price.

What Humana Inc does

Humana provides health insurance plans and related healthcare services. It sells Medicare Advantage plans, commercial health insurance, military healthcare coverage, and pharmacy benefit management to individuals, employers, and government program participants. Its shares trade on NYSE under the ticker HUM.

Revenue and profit by year

Revenue
FY18: $56.9B $56.9B FY18FY19: $64.9B $64.9B FY19FY20: $77.2B $77.2B FY20FY21: $83.1B $83.1B FY21FY22: $92.9B $92.9B FY22FY23: $106.4B $106.4B FY23FY24: $117.8B $117.8B FY24FY25: $129.7B $129.7B FY25
Net income
FY18: $1.7B $1.7B FY18FY19: $2.7B $2.7B FY19FY20: $3.4B $3.4B FY20FY21: $2.9B $2.9B FY21FY22: $2.8B $2.8B FY22FY23: $2.5B $2.5B FY23FY24: $1.2B $1.2B FY24FY25: $1.2B $1.2B FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$129.7B$2.7B$1.2B$9.84$375M
2024$117.8B$2.6B$1.2B$9.98$2.4B
2023$106.4B$4B$2.5B$20.00$3B
2022$92.9B$3.8B$2.8B$22.08$3.5B
2021$83.1B$3.1B$2.9B$22.67$920M
2020$77.2B$5B$3.4B$25.31$4.7B

Full financial statements: income, balance sheet and cash flow

Next report expected around November 4, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 5, 2025. Not a date the company has announced. See the report calendar

Where HUM ranks in Health care

Revenue$129.7B
#8 of 750 in Health care · Top 1%
Revenue growth+10.1%
#283 of 532 in Health care · Bottom 47%
Net margin0.9%
#209 of 543 in Health care · Top 38%
Free cash flow margin0.3%
#238 of 489 in Health care · Top 49%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

Humana Inc paid $3.54 per share in fiscal 2025. At the current price that is a yield of 0.88%. It paid out $430M in cash dividends, 36% of its net income.

Fiscal yearPer sharePaid outOf profit
2025$3.54$430M36%
2024$3.54$431M36%
2023$3.44$431M17%
2022$3.06$98M3%
2021$2.73$90M3%
2020$2.43$323M10%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Humana Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 1, 2026
  2. July 29, 2026
    Quarterly report 10-Q · period to June 30, 2026
  3. July 29, 2026
  4. July 29, 2026
  5. June 24, 2026
  6. June 24, 2026
  7. June 1, 2026
  8. May 19, 2026
  9. May 14, 2026
  10. April 30, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 2, 2026. Insider transactions on SEC

What is HUM worth? A DCF from its reported cash flow

Insider trades

What the people running Humana Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 3 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
September 1, 2026 Nundy ShantanuChief Medical Officer Received as pay 2,549 - - Form 4
August 1, 2026 Crawford Frederick JohnDirector Received as pay 544 - - Form 4
August 1, 2026 Smith Paul JohnDirector Received as pay 544 - - Form 4
May 1, 2026 Mellet CelesteChief Financial Officer Received as pay 15,387 - - Form 4
May 1, 2026 Ventura Joseph CChief Legal Officer Received as pay 10,318 - - Form 4
May 1, 2026 O'Hara Michelle A.Chief Human Resources Officer Received as pay 10,485 - - Form 4
May 1, 2026 Shetty Sanjay KPresident, CenterWell Received as pay 9,945 - - Form 4
May 1, 2026 Rechtin James A.President & CEO Received as payindirect 35,633 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns HUM

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Dodge & Cox13G, passive 9.5% 11,380,673 May 14, 2026
Vanguard Capital Management13G, passive 7.55% 9,068,300 April 30, 2026

Latest filings below 5%: The Vanguard Group 0% (March 27, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 924 managers reported a position.

HolderSharesValueChange on quarter
Dodge & Cox10,940,380$4.35B-440,293
BlackRock, Inc.10,417,803$4.14B+218,748
Vanguard Capital Management LLC7,843,620$3.12B+4,858
Vanguard Portfolio Management LLC5,818,956$2.31B+10,521
State Street Corp5,457,072$2.17B+4,080
Pzena Investment Management LLC4,403,136$1.75B-1,067,846
Massachusetts Financial Services Co3,578,245$1.66B-904,125
Eagle Capital Management LLC3,846,762$1.53B+879,688
Sessa Capital IM, L.P.3,727,740$1.48B0
Geode Capital Management, LLC3,369,757$1.34B+43,062
Jpmorgan Chase & Co3,234,637$1.26B+200,409
Fmr LLC2,913,763$1.16B+79,461
Capital International Investors2,392,826$950.5M+406,678
Goldman Sachs Group Inc2,299,889$913.6M+393,995
Naya Capital Management UK Ltd1,833,763$728.4M+168,641
Norges Bank1,748,414$694.5Mnew
Invesco Ltd.1,478,788$587.4M-907,025
Charles Schwab Investment Management Inc1,370,831$544.5M+84,174
Morgan Stanley1,349,066$535.9M-98,531
Dimensional Fund Advisors LP1,122,669$445.8M-89,205

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

17 insiders reported holding 275,061 shares in total, about $111.1M at the last price.

HolderSharesAs of
Rechtin James A.President & CEO 63,93863,938 held indirectly May 1, 2026
Mellet CelesteChief Financial Officer 39,637 May 1, 2026
Ventura Joseph CChief Legal Officer 27,405 May 1, 2026
Dintenfass DavidPresident, Enterprise Growth 25,407 May 1, 2026
Martin AaronPresident, Medicare Advantage 25,237 May 1, 2026
Shetty Sanjay KPresident, CenterWell 22,088 May 1, 2026
O'Hara Michelle A.Chief Human Resources Officer 20,026 May 1, 2026
Mehta JapanChief Information Officer 17,176 May 1, 2026
Renaudin George IIPresident, Insurance 16,075 February 24, 2026
Felter John-Paul W.SVP, Chief Accting Off & Cont. 7,484 February 24, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about HUM

What does Humana Inc do?

Humana provides health insurance plans and related healthcare services. It sells Medicare Advantage plans, commercial health insurance, military healthcare coverage, and pharmacy benefit management to individuals, employers, and government program participants. Its shares trade on NYSE under the ticker HUM.

What is Humana Inc's net worth?

Humana Inc has a market value (market cap) of $48.5B at the latest share price, and shareholders' equity of $18.6B on its balance sheet at March 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Humana Inc profitable?

Yes. Over the twelve months to March 31, 2026 it reported net income of $1.1B on revenue of $137.2B, a net margin of 0.8%.

How much revenue does Humana Inc make?

Over the twelve months to March 31, 2026 Humana Inc reported revenue of $137.2B. That is 14.1% more than a year earlier.

When did Humana Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 29, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from October 2, 2026.

When is Humana Inc's next earnings report?

Humana Inc's next report is expected around November 4, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Does Humana Inc pay a dividend?

Yes. Humana Inc paid dividends of $3.54 per share in fiscal 2025, a yield of 0.88% at the current price.

Similar companies

Compare HUM with

Compare HUM with any company

Follow HUM

Get an email when Humana Inc files with the SEC: results, executive changes, material agreements and annual reports.

Follow HUM: get an email when it files

Where the numbers come from

Financial figures are the values Humana Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.